The relationship between the degree of brain edema regression and changes in cognitive function in patients with recurrent glioma treated with bevacizumab and temozolomide

Abstract

Background: This retrospective study aims to assess the impacts on cognitive status and quality of life in recurrent high-grade glioma patients treated with temozolomide (TMZ), either alone or in combination with bevacizumab (BEV), and explore the relationship between the brain edema regression, BEV use, and cognitive status.Methods: A total of 125 patients with recurrent high-grade glioma were enrolled in this study, of which 65 patients were treated with BEV (5-10 mg/kg IV every 2 weeks) plus TMZ (200 mg/m 2 every 28 days, d1-5), and 60 patients were treated with TMZ (200 mg/m 2 every 28 days, d1-5) alone. The treatment response was evaluated using the Response Assessment in Neuro-Oncology (RANO) criteria. Tumor-associated edema was evaluated with T2WI magnetic resonance imaging (MRI) and quantitative T2 mapping sequence, and an Edema Regression Index was designed to quantify volumetric changes in edema imaging after every treatment cycle. Cognitive intelligence state and quality of life were evaluated using the Mini-Mental State Examination (MMSE) and the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (QLQ-C30).Results: Radiologically, the partial response rate was 78.5% in the BEV + TMZ group and 38.3% in the TMZ group. After the first cycle of treatment, the mean score of the MMSE was 21.1±2.0 and 24.1±1.4 (P<0.001) in the TMZ group and the BEV + TMZ group, respectively. In the functioning domains of the QLQ-C30, scales of physical functioning, emotional functioning and cognitive functioning were 43.0±7.0 vs. 61.7±12.5 (P<0.001), 44.5±8.8 vs. 63.4±6.9 (P<0.001) and 42.4±8.8 vs. 63.7±12.0 (P<0.001) in the TMZ group and the BEV + TMZ group, respectively. In the BEV + TMZ group, a correlation between the Edema Regression Index and improvement in cognitive status and quality of life was observed. Patients with Edema Regression Index scores higher than 50% gained a 25.6% increase in the mean MMSE score from 19.9±1.6 to 25.0±1.1 (P<0.001). In the BEV + TMZ group, physical functioning, emotional functioning, and cognitive functioning increased by 76.8%, 53.1%, and 81.5%, respectively, while scores of nausea/vomiting decreased by 40.3% to 32.1. Patients with no evident edema observed in the pre-BEV MRI scans were given a prolonged four-cycle course of BEV. No significant improvement was observed in the MMSE score and the QLQ score with additional cycles of BEV.

Perfusion magnetic resonance imaging in the differentiation between glioma recurrence and pseudoprogression: a systematic review, meta-analysis and meta-regression

“…In the process of postoperative radiation therapy for glioma, it is easy to cause brain damage (56). As it usually occurs weeks to months after radiotherapy (8,57), PsP is difficult to distinguish from tumor recurrence (58).…”

Symptom Burden in Glioblastoma: A Prospective Pilot Study from Diagnosis to First Progression

“…The individual symptom profile is also associated with the anatomical region being affected and takes the post-therapeutic tumor burden (biopsy, partial resection) into account. Remaining tumor causes brain edema, tumor hemorrhage, and metabolic changes, which might lead to headache, seizures, fatigue, cognition disturbances, and depression [19,20]. Furthermore, neurological and performance deficits in our study measured by the NIH-SS and the KPS may interfere with the nonphysical symptoms reported by a given patient.…”

A common low dimensional structure of cognitive impairment in stroke and brain tumors

“…The map highlighted the left peri -sylvian region that was one of the regions predictive in stroke. A link between oedema and cognitive function has been described in relation to radiotherapy treatment ( Wang et al, 2021 ). Recently, we showed abnormal functional connectivity in cortical regions remote from the tumor core, but presumably connected to it by anatomical fibers that travel through the surrounding oedema region ( Silvestri et al, 2022 ).…”